Research programme: inflammation modulators - Inimex

Drug Profile

Research programme: inflammation modulators - Inimex

Alternative Names: Cationic peptides for inflammation - Inimex; IDRs - Inimex; IMX 002; IMX 002 compounds; Innate Defense Regulators - Inimex; Product II programme - Inimex

Latest Information Update: 07 Mar 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Inimex Pharmaceuticals
  • Class Small molecules
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Preclinical Inflammation; Psoriasis; Rheumatoid arthritis

Most Recent Events

  • 08 Mar 2006 This programme is available for licensing (
  • 08 Mar 2006 Preclinical trials in Inflammation in Canada (unspecified route)
  • 08 Mar 2006 Preclinical trials in Psoriasis in Canada (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top